HCPCS code J1203 — Inj, cipaglucosidase, 5 mg. Status: Active. Effective Apr 1, 2024. Source: CMS HCPCS Level II.

J1203

Active

Inj, cipaglucosidase, 5 mg

Injection, cipaglucosidase alfa-atga, 5 mg

Category: Drugs
Section: J-codes: Drugs Administered Other Than Oral Method
Effective: Apr 1, 2024
Code type: alphanumeric
OPPS Status: G — Pass-through drugs and biologicals
OPPS APC: 0737

MUE — Medically Unlikely Edits

Maximum units of J1203 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.

Service Type Max Units / Day
DME Supplier 630
Outpatient Hospital 630
Practitioner Services 630

Source: CMS Medicare NCCI Medically Unlikely Edits

NDC Crosswalk

National Drug Codes (NDCs) mapped to this HCPCS code.

NDC Drug Name
71904-0200-01 Pombiliti

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2024-Q2
    Inj, cipaglucosidase, 5 mg